Article
Vorasidenib-Induced Acute Liver Injury
2026-06-30
Abstract excerpt
<title>Abstract</title> <p>Background and Aims: Vorasidenib is a dual inhibitor of isocitrate dehydrogenase-1 and isocitrate dehydrogenase-2 that is used to treat patients with Grade 2 astrocytoma or oligodendroglioma with either mutations after surgery. Vorasidenib has yet to be linked to cases of acute liver injury. We describe 3 cases of severe acute liver injury with features of autoimmune hepatitis associate...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 30885805-b325-5977-acfe-a0693eea1248
- DOI
- 10.21203/rs.3.rs-9391169/v1
